Concepedia

Raffaella De Fato

RD

Statistics

Publications

3

Citations

357

H-Index

3

Active since

2016

Affiliations

Fondazione Michelangelo(Current)

San Raffaele University of Rome

Azienda Sanitaria Universitaria Integrata di Trieste

Azienda Ospedaliera S.Maria

Raffaella De Fato is an author at Fondazione Michelangelo specializing in oncology, medicine, and pharmacology.

Publications per year

2016–2018

3

Publications

3

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study

Luca Gianni, Giancarlo Bisagni, Marco Colleoni et al. · The Lancet Oncology · 2018 · 172 citations

, , +14

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With <i>ERBB2/HER2</i> -Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial

Luca Gianni, Mauro Mansutti, Antonio Antón et al. · JAMA Oncology · 2018 · 155 citations · Full text

, , +17

Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure

Andrea Necchi, Andrea Anichini, Daniele Raggi et al. · Clinical Genitourinary Cancer · 2016 · 30 citations

, , +13

1–3 of 3